NANO Nuclear Energy (NNE) has been drawing fresh attention after scheduling a Fiscal Year 2025 business update webcast and signing agreements to test its microreactors in real world data center and Texas facility settings.
See our latest analysis for NANO Nuclear Energy.
Those data center and Texas deployment plans seem to be shifting how investors are thinking about NANO Nuclear’s growth runway. The share price is at $32.31 after a 1 year to date share price return of 35.02 percent and a 1 year total shareholder return of 25.48 percent, suggesting longer term momentum is still building despite some recent pullbacks.
If this kind of speculative clean energy story is on your radar, it is also worth exploring other high growth tech and infrastructure plays using our high growth tech and AI stocks to spot what else is gaining traction.
With the stock already up strongly this year and trading at a steep discount to its ambitious analyst target, the key question now is simple: Is NANO Nuclear still mispriced, or has the market already baked in years of growth?
At a last close of $32.31, NANO Nuclear is trading on a rich price to book ratio of 7.1 times, signaling a premium to peers rather than a bargain.
The price to book multiple compares the company’s market value to its net assets, a common way to value capital intensive, asset heavy businesses like those in the electrical and nuclear technology space.
For NANO Nuclear, a 7.1 times price to book ratio looks demanding given the company is currently unprofitable and generates less than 1 million dollars in revenue. Analysts also expect the company to remain loss making over the next three years even as revenue is expected to scale quickly.
That premium stands out even more against the wider US Electrical industry, where the average price to book ratio is 2.5 times. NNE also screens as expensive relative to its closest peers, which cluster around 6.7 times.
See what the numbers say about this price — find out in our valuation breakdown.
Result: Price to Book ratio of 7.1x (OVERVALUED)
However, significant execution risk around commercialising ZEUS and ODIN, as well as ongoing losses and funding needs, could quickly puncture the current growth narrative.
Find out about the key risks to this NANO Nuclear Energy narrative.
If you see the story differently or want to dig into the numbers yourself, you can build a custom view in just a few minutes: Do it your way.
A great starting point for your NANO Nuclear Energy research is our analysis highlighting 2 key rewards and 5 important warning signs that could impact your investment decision.
Before you move on, lock in your next opportunities by using the Simply Wall St Screener to spot high potential stocks that most investors are still overlooking.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com